Background: High intakes of trans fatty acids (TFA) have been found to exert an undesirable effect on serum lipid pro®les, and thus may increase the risk for cardiovascular disease. Objective: Investigation of the association between TFA intake and serum lipids. Design: Cross-sectional study in eight European countries (Finland, France, Greece, Iceland, The Netherlands, Portugal, Spain, Sweden) among 327 men and 299 women (50 ± 65 y). Using a dietary history method, food consumption was assessed and TFA intake was calculated with recent ®gures on TFA levels of foods, collected in the TRANSFAIR study. Results: Mean ( AE s.d.) TFA intake was 2.40 AE 1.53 gaday for men and 1.98 AE 1.49 gaday for women (0.87 AE 0.48% and 0.95 AE 0.55% of energy, respectively), with the highest consumption in Iceland and the lowest in the Mediterranean countries. No associations were found between total TFA intake and LDL, HDL or LDLaHDL ratio after adjustment for cardiovascular risk factors. Additional adjustment for other fatty acid clusters resulted in a signi®cant inverse trend between total TFA intake and total cholesterol (P trend`0 .03).The most abundantly occurring TFA isomer, C18:1 t, contributed substantially to this inverse association. The TFA isomers C14:1 t9, C16:1 t9 and C22:1 t were not associated or were positively associated with LDL or total cholesterol. Conclusions: From this study we conclude that at the current European intake levels of trans fatty acids they are not associated with an unfavourable serum lipid pro®le.
Introduction
Since controlled experimental human studies have shown that an increase in dietary trans fatty acid (TFA) intake has an undesirable effect on serum lipid pro®les (Mensink & Katan, 1990; Mensink et al, 1992; Nestel et al, 1992; Judd et al, 1994) , concerns about their role in the etiology of cardiovascular diseases have risen. Furthermore, some studies (Mensink et al, 1992; Nestel et al, 1992; Judd et al, 1994) , but not all (Clevidence et al, 1997) , have shown an adverse effect of TFA on lipoprotein(a) levels. With their straight-chain con®guration, TFA resemble the saturated fatty acid structure. They naturally occur in products originating from ruminant animals and are industrially produced through partial hydrogenation (`hardening') of vegetable and marine oils in order to produce dietary fats with better structure and stability. Hydrogenated fats are widely used in food products as a substitute for saturated fats (eg margarines, shortenings and frying fats). Estimates of intake during recent decades have varied between 2.6 and 12.8 gaday in the USA and between 2.0 and 17.4 gaday in Europe (Precht & Molkentin, 1995; Becker, 1996; Special Task Force, 1996; Allison et al, 1999) , with the lowest estimates obtained from food frequency questionnaires.
Several epidemiological studies have investigated the association between high intake of TFA and cardiovascular disease (CVD). A US cross-sectional study has revealed weak but signi®cant positive associations between TFA intake and serum total cholesterol and LDL cholesterol and a negative association with HDL cholesterol (Troisi et al, 1992) . In large prospective studies TFA intake was positively associated with CVD risk among US women (Willett et al, 1993) and men (Ascherio et al, 1996) , although in the latter study the association disappeared after further adjustment for dietary ®bre. Additionally, a positive association between TFA intake and risk of a ®rst myocardial infarction has been described in a case-control study (Ascherio et al, 1994) .
Epidemiological studies in Europe have produced conicting results. In a cohort of Finnish men, risk of coronary death was signi®cantly elevated in the highest quintile of TFA intake (Pietinen et al, 1997) .
Case-control studies on biomarkers of TFA intake have shown no overall association between adipose tissue levels of the C18:1 trans isomer and myocardial infarction risk (Aro et al, 1995) and no association between the TFA content of plasma phospholipids and severity of coronary atherosclerosis (Van de Vijver et al, 1996) . Data from the Euramic study, however, showed marked differences among European countries. Separate analysis for Norway and Finland showed elevated odds ratios for myocardial infarction in the highest quartile of adipose C18:1 TFA concentration, whereas for Spain and Russia the opposite was seen. This observation suggests that there is either an interaction of C18:1 trans with some other dietary factor (s) or C18:1 trans intake is not aetiologically related to myocardial infarction, but serves rather as a marker of other dietary factors.
So far, European cross-sectional data on realistic consumption levels of trans fatty acid and serum lipid levels have been lacking. In the TRANSFAIR study, a crosssectional investigation in eight countries in Europe, intake of trans-isomers of C14:1, C16:1, C18:1, C18:2 and C22:1 was studied in relation to serum lipid fractions, taking into account the possible in¯uence of other fatty acids in the diet. The results of this study should help clarify the discrepant ®ndings on the relation between dietary TFA and CVD risk.
Materials and methods
This study was part of a European concerted action on TFA and their relationship with CVD risk factors. In the ®rst part of the study the fatty acid content of food products in 14 European countries was determined (part 1). Subsequently, these data were used in assessing dietary TFA acid intake in a representative food consumption survey, part 2). Finally a cross-sectional study investigated whether intake of TFA is related to the prevalence of CVD risk factors (part 3). The results of this latter study are described here.
In eight European countries apparently healthy men and women, aged 50 ± 65 y, were selected from the general population. Subjects were recruited from population registers (Helsinki, Finland; Reykjavik, Iceland; Zeist, The Netherlands; Uppsala, Sweden), university employees (Tours, France), or the sample was a combination of employees and subjects recruited via registers (Segovia, Spain; Crete, Greece; Lumiar, Portugal). Subjects were invited by means of a personal mailing. Response rates for these mailings were 20 ± 66% for men and 25 ± 72% for women. In Greece (Crete), interest for the study was elicited through a note with details on the study; when they were willing to participate, subjects were asked to contact the investigators on a ®rst come-®rst served basis. In Spain, women were recruited from members of a housewives' association who, after attending a lecture explaining the study, were asked to participate. In the study only postmenopausal women not using hormone replacement therapy were eligible. Men and women who used lipidlowering medication, or who reported a change in the use of a lipid-lowering diet or a change in the use of fatty acidcontaining food supplements in the 6 months prior to the study were excluded. Further, subjects who reported chronic disease (myocardial infarction, stroke, diabetes, cancer) or a change of weight of more than 5 kg over the past year, and subjects who were mentally disabled were excluded. Subjects on a speci®c dietary regimen (veganism or macrobiotics) were excluded as the structured dietary history was not suitable for use by those subjects. In total, 327 men and 299 women participated.
Data collection
For data collection a uniform questionnaire was used, and the same questions were asked in the same order for each country (in the local language). Information was gathered on smoking habits (smoking status, number of cigarettesacigars, when did you stop smoking, did you ever smoke pipe or tobacco, do you live or work with someone who smokes), socio-economic status (SES, with every country making its own division into low, medium and high SES), education (years of full-time education), family history of CVD (mother or father died of CVD), physical activity (time spent on light, moderate and heavy activity) and presence of CVD (questionnaire of the London School of Hygiene; Rose et al, 1982) . Height was recorded with the subject wearing no shoes and weight was measured by using a calibrated scale, with the subject wearing no shoes and only one layer of light clothing. The circumferences of waist and hip were measured midways between the lower rib margin and the iliac crest and at the maximum circumference over the buttocks, with the subject in standing position. After the subject had been sitting for at least 5 min blood pressure was measured in duplicate using a standard mercury sphygmomanometer.
Fatty acids in foods
To obtain data on TFA and other fatty acids in foods, a market basket study was performed in 14 European countries (Belgium, Denmark, Finland, France, Germany, Spain, Greece, Iceland, Italy, The Netherlands, Norway, Portugal, Sweden and UK). In each country, a maximum of 100 food samples representative of fat intake and contributing to 95% of total fat intake were collected and analysed in a central laboratory. Selection of foods, sample handling and analytical methods have been described in detail elsewhere . Brie¯y, sampling was performed following a stepwise approach. Samples were purchased in regular commercial outlets for consumer products, except for some products for industrial use. For practical reasons, the number of foods in each country was restricted to 100 through selection among foods with similar fat composition and by producing aggregates of different brands of similar foods (data provided by national industries on a con®den-tial basis). All sampling took place between June 1995 and April 1996. Samples were homogenized, frozen and stored at 720 C and transported to central laboratory facilities at the TNO Nutrition and Food Research Institute in Zeist. Fats were extracted, total fat content was determined, and fatty acid methyl esters were separated by capillary gas chromatography. Fatty acids were identi®ed through comparison with standards. A total of 44 fatty acids or groups of fatty acids with 8 ± 26 carbon atoms were identi®ed, including seven trans isomers or trans isomer groups.
Trans fatty acids and CVD risk factors LPL van de Vijver et al C18:1 and C18:2 TFA were calculated as groups because of incomplete separation between individual fatty acid isomers . Results were reported as mg fatty acid methyl esters per 100 g food. A database was compiled comprising the analytical data for each country separately. The main results have been published elsewhere (Aro et al, 1998a ± c; . Since a maximum of 100 foods per country were analysed, each country had to prepare its operational database with estimates of individual trans and other fatty acids and clusters of fatty acids in all foods (in absolute amounts and as percentage of energy intake), completed with information from other sources, such as TRANSFAIR analyses from other countries for comparable foods, information from National Food Composition Tables and from the literature. For a few foods in which the quantity of a certain separable TFA could not be determined, zero content was assumed.
Dietary history
A structured meal pattern-based dietary history according to national consumption patterns was used for the assessment of energy and nutrient intake. In all participating centres, dietary assessment took place in the months March ± May. The interview was held at the participant's home or local health centre by a trained dietitian. Food intake was inquired over the past month. Frequency of consumption was reported in 10 categories: never, 1 daya month, 1 dayafortnight, 1 dayaweek, 2 daysaweek, 3 daysa week, 4 daysaweek, 5 daysaweek, 6 daysaweek, every day. For each consumption day, the number of portions was asked for and portion sizes were assessed in household measures and afterwards weighed at the subject's home. When weighing was not possible, household measures were assessed with the help of photographs of food portions. Completeness and reliability of the questionnaire based on reported frequency of consumption, and the credibility of the reported numbers of servings was checked by a dietitian. Subjects with extreme low or high energy intakes were individually checked. The dietician of the coordinating centre decided in consultation with the dietician of the country of origin whether or not this subject should be excluded from further analyses. Additionally, information on food supplements contributing to energy, total fat and fatty acid intake was gathered. By using the national operational database based on analyses from the ®rst part of the TRANSFAIR study Aro et al, 1998a ± c; , total energy, total fat, fatty acid isomers, fatty acid clusters, total carbohydrates, alcohol and energy intake were calculated in grams and as percentage of total energy (en%).
Adipose tissue and blood sampling
A 12 h fasting venous blood sample was drawn in a 10 ml tube. Blood was kept at ca 4 C for at least 1 h before centrifuging to separate the serum. Serum samples were stored at 770 C. In a subsample of the study population in each of the participating centres (n 322), subcutaneous adipose tissue was taken from the buttock by needle aspiration and stored at 770
C within 1 h after sampling (Beynen & Katan, 1985) .
Blood lipids
Blood lipids were measured at the National Institute of Health in Lisbon as the central laboratory. Total cholesterol content of plasma was determined by use of an autoanalyser (Hitachi BM-911) with an enzymatic colorimetric test using CHOD-PAP reagent (Boehringer Mannheim). Triglycerides were measured by the GDO-PAP method (Boehringer Mannheim) by colorimetric determination with an auto-analyser (Hitachi BM-911) of liberated glycerol after enzymatic hydrolysis of triglycerides. HDL cholesterol was directly determined quantitatively in an in vitro assay (Boehringer Mannheim); LDL cholesterol levels were calculated with the Friedewald formula.
Fatty acid composition of adipose tissue
The fatty acid composition of the adipose tissue samples was analysed at the National Public Health Institute in Helsinki as the central laboratory. The adipose tissue samples were transported on dry ice (740 C) from each of the participating centres to Finland. Immediately after arrival samples were stored in the freezer at 770 C until analysis. The biopsy sample was extracted with hexane ± isopropanol 3 2 (Hara & Radin, 1978) and the raw fat was transmethylated with acidic methanol (Stoffel et al, 1959) . Fatty acid patterns were determined by gas chromatography. A fused silica capillary column SP2380, 60 m60.32 mm (length6i.d.), d.f. 0.2 mm, and wall thickness 0.2 mm, was used (temperature program from 140 to 230 C), with helium as carrier gas and a split-type injection system. The fatty acid composition from C12 to C22 was analysed and the composition was normalized to 100%. Peak identi®cation in biopsy samples was based on available standards, retention time of a fatty acid eluting from columns with different polarities and argentation thin-layer chromatography. In addition, natural materials were used to con®rm some identi®cations. About 97 ± 99% of all fatty acids were identi®ed. The inter-assay coef®cient of variation of control samples was 2 ± 6% for peaks over 1%, 4 ± 8% for most peaks under 1%, and 14 ± 25% for some very small or nearly overlapping peaks.
Statistical analysis
Analyses were performed for men and women separately, with the data of the different centres pooled. First, the appropriateness of pooling the data was tested by adding interaction terms of country and TFA intake to regression models with TFA intake and country as the explanatory variables and serum lipid levels as the response variable. Analysis of covariance was used to calculate mean serum lipid levels per quintile of total TFA intake. Data were adjusted for a ®xed set of potential confounders: age, gender, country, smoking status, number of cigarettes, energy intake, alcohol intake, family history of CVD, presence of angina pectoris, body mass index (BMI) and waistahip ratio (WHR). In a second model, additional adjustment was made for the other fatty acid clusters, ie polyunsaturated (PUFA), monounsaturated (MUFA) and saturated fatty acids (SFA). Data on physical activity were missing for one country and therefore not included in the ®xed set of confounders. In a separate analysis in the subset with complete data, additional adjustment for physical activity was made. Linear regression was applied to assess the relationship between TFA intake, taken as a continuous explanatory variable, and serum lipid levels as the response variable. Data were adjusted for the confounding factors used for total TFA intake in analysis of covariance.
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To validate dietary intake data, Spearman correlations with fatty acid groups in adipose tissue were calculated. The statistical package SAS was used in data analyses. Table 1 lists the characteristics of the study population. Mean total cholesterol levels (AE s.d.) were 5.7AE 1.0 mmolal in men and 6.2 AE 1.1 mmolal in women. Mean daily energy intake was 10.1 AE 2.9 MJ for men and 7.6 AE 2.1 MJ for women. The mean contribution of fat to energy intake was 34% for men and 35% for women. In Table 2 country speci®c lipid levels are presented. The highest LDL cholesterol levels combined with the lowest HDL levels were found in Greek and Icelandic men, resulting in an LDLaHDL ratio of 3.4 AE 1.1 and 3.4 AE 1.6, respectively. The lowest ratio in men was found in France, ie 2.4 AE 0.6. For women the highest LDLaHDL ratio was seen in Iceland (3.0 AE 1.3) and the lowest in France (2.3 AE 0.8).
Results
In Table 3 fatty acid intakes for men and women are presented both in absolute amounts and as percentage of energy. Absolute intake of TFA was 2.4 gaday (range 0.1 ± 12.5 gaday) in men and 2.0 gaday (range 0.3 ± 18.3 gaday) in women. TFA intake as percentage of energy intake was 0.9 en% (range 0.1 ± 3.8 en%) for men and 1.0 en% (range 0.2 ± 5.7 en%) for women. Table 4 shows intake of TFA and other fatty acid clusters for each country, for men and women separately. Total fat intake among men ranged from 28 en% in Portugal to 40 en% in Spain, and among women from 29 en% in Portugal to 42 en% in Spain. Total TFA intake was highest in Iceland both for men and for women (respectively, 3.8 AE 2.3 and 3.3 AE 2.9 gaday). The main contributor to total TFA was the C18:1 TFA isomer, accounting for 54 ± 76% of total TFA intake.
Correlations between the fatty acid clusters (en%) showed a strong positive gender-adjusted correlation between total TFA and total SFA (overall r 0.71). For Trans fatty acids and CVD risk factors LPL van de Vijver et al the separate countries, lowest correlations were found for Sweden (r 0.32) and Iceland (r 0.47), whereas the highest correlations were seen in Spain (r 0.78) and Portugal (r 0.80). Correlations between SFA and the separate TFA isomers revealed signi®cant positive associations for all but C22:1 t. Overall an inverse correlation between total TFA and MUFA (r 7 0.14, P`0.01) and no correlation between total TFA and PUFA was detected.
The correlations between the TFA isomers, calculated per country, revealed signi®cant positive associations between most combinations of TFA isomers. However, the associations between the C22:1 t isomer and the other TFA isomers were markedly weaker. Overall the correlation coef®cient of total TFA with the separate isomers were: 0.57 (C14:1 t9), 0.68 (C16:1 t9), 0.96 (C18:1 t), 0.84 (C18:2 t) and 0.43 (C22:1 t). We calculated partial correlation coef®cients for the association between total TFA intake and lipid levels, adjusted for gender. TFA, both expressed as gaday and as en%, was inversely correlated with LDL and total cholesterol, although signi®cance was reached only when total TFA was expressed in absolute amounts (r 70.10 and r 70.10 for LDL and total cholesterol, respectively). For the separate countries, a signi®cant association between total TFA intake and total cholesterol was found only in Iceland (r 70.26).
Because the inverse association was opposite to our hypothesis, we tested whether the association for SFA was in the expected direction. Partial correlations, adjusted for gender, were calculated between SFA intake expressed as en % and lipid levels. Associations were all non-signi®cant, but showed a positive tendency for LDL cholesterol (r 0.08) and total cholesterol (r 0.05 and a negative tendency for HDL cholesterol (r 70.03).
In Table 5 mean adjusted levels of LDL, HDL, LDLaHDL ratio and total cholesterol are presented per Additional adjustment for fatty acid clusters.
Trans fatty acids and CVD risk factors LPL van de Vijver et al quintile of TFA intake. No association was seen for LDL, HDL or the LDLaHDL ratio. For total cholesterol an inverse trend over the successive quintiles of TFA intake was found, which reached signi®cance only after additional adjustment for the other fatty acid clusters. In Table 6 the results from the linear regression models for the separate TFA isomers are presented. In the regression model adjustment was made for the same set of covariables as used in analysis of covariance. Serum LDL levels were positively associated with C14:1 t9 and C22:1 t intake, whereas LDL was inversely associated with C18:1 t and C18:2 t after additional adjustment for the other fatty acid clusters. For the associations between HDL levels and TFA isomers, only the inverse association with C16:1 t9 intake reached signi®cance. The LDLaHDL ratio was positively associated with C14:1 t9, C16:1 t9 and C22:1 t. Total cholesterol was positively associated with C14:1 t9 and C22:1 t, whereas inverse associations were seen with total TFA intake and with C18:1 t and C18:2 t intake. Further, adjustment for years of education or physical activity had only a minor impact on the results (not shown). When the association between C18:1 t and lipid levels was adjusted for other TFA isomers (model 2 C14:1 t9, C16:1 t9 and C22:1 t), the inverse association with LDL and total cholesterol became slightly stronger (70.19 AE 0.06 and 70.23 AE 0.06, P`0.01, respectively).
In the regression analyses adjustment for country was made, so that unknown country-speci®c factors could be controlled for. The appropriateness of pooling was tested by including interaction terms in the model. However, adjustment for country may also lead to a reduction of the variation in TFA intake. Performing the analysis without adjustment for country did not have large impact on the results. Only for the minor TFAs (C14:1 t9 and C22:1 t) was the association with LDL no longer signi®cant. Because these minor TFAs were consumed in only a few countries, a country-adjusted model will give a better estimate for the association of these TFAs with plasma lipids.
In Table 7 the regression coef®cients for total TFA and total, LDL and HDL cholesterol are presented per country. Because of the small numbers, the statistical power of these analyses is small and only in Iceland was a signi®cant association detected.
Regression analyses over the pooled data were also performed with the exclusion of Iceland, because the Icelandic data had a large impact on the results. After exclusion the association between total TFA intake and total cholesterol no longer reached signi®cance (b AE s.d. 0.00 AE 0.07). For the separate TFA isomers, positive associations between C14:1 t9 and LDL and total cholesterol (model 1) remained. For C16:1 t9 the associations became slightly stronger and resulted in a positive association with LDL (model), LDLaHDL ratio and total cholesterol (model 1). The inverse association between C18:1 t and total cholesterol disappeared. Further, an increase in the strength of the association between C22:1 t9 and LDL, LDLaHDL and total cholesterol was seen, which resulted in b-coef®- To exclude the possible presence of familiar hypercholesterolaemia, analysis was also performed without those participants who had a total cholesterol level above 8 mmolal (n 31). The results of regression analysis were comparable to those in the total study population.
Validation of dietary intake with adipose tissue levels
In this study adipose tissue samples of half of the participating men and women for every country were collected to validate calculated intake levels. The correlations between fatty acid intake expressed as percentages of total fatty acid intake and adipose tissue levels were calculated. Spearman correlation coef®cients were: 0.67 for total TFA, 0.36 for C16:1 t and 0.63 for C18:1 t. The correlation between the sum of linoleic and linolenic acid with total dietary PUFA was 0.35. All these associations were signi®cant at P`0.01. The association between dietary and adipose total trans fatty acids is presented in Figure 1 .
Discussion
In this cross-sectional study among middle-aged men and women, no associations were observed between total TFA intake and LDL and HDL cholesterol levels, and a weak inverse association between total TFA intake and total serum cholesterol was found. Marked differences in the association between serum lipids and separate TFAs were detected. For C18:1 t, the most common TFA, an inverse association with LDL and total cholesterol was seen. Other TFA isomers (C14:1 t9, C16:1 t9 and C22:1 t), which were consumed in smaller amounts, were not associated or were positively associated with LDL or total cholesterol.
This was the ®rst cross-European study in which the association between habitual TFA intake and blood lipids was investigated. Interventions studies have clearly shown the importance of high total or C18:1 TFA intake on serum lipid levels. This study now offers the opportunity to assess the importance of TFAs under normal uncontrolled conditions, with the additional value that not only the associations between C18 trans but also other TFA isomers and serum lipids can be studied. For this purpose we aimed at a wide variety in TFA intakes in the study population. Therefore, eight countries, both northern and southern European countries, participated, which led to an actual variation in mean intakes of a factor 3.
To calculate TFA intake, ®gures were used from recent analyses, also in the TRANSFAIR study Aro et al, 1998a ± c; , in which the TFA contents of foods contributing to more than 95% of fat intake in a country were analysed. Thus far data on TFA content had been scanty and the basis for calculations in most studies was a rough estimate of the C18:1 t isomer intake level. In this study, a high uniformity of TFA measurement was achieved because all participating Figure 1 Correlation between dietary and adipose tissue trans fatty acids, indicated per country.
Trans fatty acids and CVD risk factors LPL van de Vijver et al countries selected foods for analysis according to a standard protocol and all foods were analysed in one central laboratory. Measurement of blood lipids was also performed centrally, therefore, differences in data collection or analysis are unlikely to have biased the results. Intake levels of TFAs found in this study were lower than those reported earlier in Northern America and several European countries. Differences in estimates can, apart from actual differences in intakes, be attributable to differences in food intake data used, differences in analytical methods used for assessing the TFA content and industrial lowering of TFA after the public turmoil on this issue in the past years (Hulshof et al, 1999) . Within the TRANSFAIR study, the TFA intake for the separate countries was estimated using data from national food surveys (TRANS-FAIR part 2). The TFA intakes calculated in part 2 of the study showed slightly higher estimates of TFA intake than those found in the present study. In the TRANSFAIR 2 study, TFA intake ranged from 0.5 en% (Greece) to 2.1 en% (Iceland) in men and from 0.8 en% (Greece) to 1.9 en% (Iceland) in women (Hulshof et al, 1999) . Differences in the study population and differences in dietary assessment methods partly explain the differences (Cameron & van Staveren, 1988) . Further, during the time elapsing between the conduct of TRANSFAIR parts 2 and 3, changes in fat composition of food products have occurred. All eight countries contributing to part 3 had the opportunity to reanalyse products and to establish current TFA levels. Five countries indeed used new values for TFAs. For instance, in Finland and The Netherlands, the updated TFA levels turned out to be substantially lower than those in part 2. To complete the fatty acid database, information on fatty acid content of foods not analysed within the framework of the TRANSFAIR study was needed. In particular, for low-fat foods and foods rarely eaten, the information is not necessarily complete. This may have slightly in¯uenced fatty acid intake estimates, but are unlikely to have in¯uenced the estimate for TFA, as most TFA-containing foods were analysed within the framework of the study.
In this part of the TRANSFAIR study a structured dietary history was used to assess dietary intake. Because the study populations were not necessarily representative of the countries, prudence is called for when using these data as a measure of TFA intake in a country. Nevertheless, the results revealed the expected pattern of fatty acid consumption for the different European countries: high intakes of MUFA were seen in the Mediterranean countries with a diet rich in olive oil; and in The Netherlands, a high intake of PUFA was found, which can be ascribed to the frequent use of margarines high in linoleic acid.
Although the same method for dietary assessment was used, differences in accuracy of reporting dietary intake in the separate countries may have occurred. Large betweencountry variations in underreporting, a major concern in food consumption assessment , may lead to a biased result. To quantify underreporting, the ratio of energy intake over basal metabolic rate (EIaBMR) was calculated (Scienti®c Committee for Foods, 1992) . The mean EIaBMR was 1.35 (1.39 for men, 1.30 for women). Low EIaBMR ratios were found in Portugese women and in Iceland. To ensure that no systematic underreporting had taken place, intake levels of carbohydrates, alcohol and fat (as en%) were compared between possible underreporters (EIaBMR`1.14; Goldberg et al, 1991) and the rest of the population. As energy percentages of fat and carbohydrates did not differ and reported alcohol intake was slightly higher in the apparent underreporters, systematic underreporting of fat intake is unlikely.
In this study saturated fatty acid intake was not signi®cantly associated with serum lipid levels. The direction of the associations, however, was as expected. Weak associations may be due to the relatively small differences in dietary saturated fatty acid intake between subjects. On the other hand, comparing this type of study to metabolic studies in which changes of cholesterol levels are assessed, only weak associations can be expected. Metabolic studies have indicated that most of the between-person variation in cholesterol levels is unrelated to dietary fats. Therefore, under ideal circumstances the correlation between saturated fatty acid intake and a single measurement of total serum cholesterol will only reach a magnitude of the order of 0.10 (Willett, 1990) .
To reduce the impact of country in the association between dietary intake and lipid levels, the regression model was adjusted for country and other classical determinants. The country speci®c data are presented, but because of the small number of subjects in each country, no conclusions as to a relation between TFA intake and cholesterol levels on a country level can be drawn. We, did however, perform additional analysis excluding Iceland. Analyses had shown that Iceland with its high intake of TFA and low cholesterol levels had a large impact on the results. Low total cholesterol levels were mainly the result of low HDL levels, which may be explained by relatively low intake levels of alcohol. In this study the reported alcohol intake in Iceland was 3.5 AE 3.8 en% for men and 1.8 AE 2.6 en% for women. For the pooled group the mean levels were 5.6 AE 6.2 and 2.3 AE 4.3 en% for men and women, respectively. Furthermore, other dietary factors may have had an impact on the HDL levels. Although typically Western, the Icelandic diet differs considerably from the other European diets. The consumption animal products, soft drinks and coffee is high and consumption of fruit and vegetables is low. For instance, the ®sh consumption in Iceland is on average 73 gaday, which is substantially higher than in most European countries (Steingrõ Âmsdo Âttir, 1993) .
Thus far several studies have examined the association between TFA intake and serum lipids. In a cross-sectional study among 748 US men aged 43 ± 85 y, Troisi et al found positive correlations between TFA intake and total and LDL cholesterol and an inverse association between TFA intake and HDL cholesterol (Troisi et al, 1992) . Adjustment for CVD risk factors and additional adjustment for intake of one of the fatty acid clusters (SFA, MUFA or PUFA) did not change the results. The study design was comparable to our study, but only men were investigated. The mean TFA intake reported was ca 3.7 AE 1.8 gaday, or 1.6 en%. This estimate of TFA intake was comparable with other estimates in the USA based on similar food frequency data (Willlet et al, 1993; Ascherio et al, 1994) , but were 1.5 ± 2-fold higher than those reported in our study among European men and women and in a study among Finnish men (Pietinen et al, 1997) .
Large epidemiological studies have investigated the association between dietary TFA intake and CVD risk. In the USA, a large cohort study among women reported an elevated risk for CVD with increased TFA intake levels (Willett et al, 1993) . In a large case-control study a two-fold Trans fatty acids and CVD risk factors LPL van de Vijver et al risk for a ®rst myocardial infarction was found in the highest (mean 6.51 gaday) compared with the lowest quintile (mean 1.69 gaday) of TFA intake (Ascherio et al, 1994) . Further, in a case-control study larger plasma TFA levels were detected in coronary stenosis patients compared to healthy controls (Siguel & Lerman, 1993) . In epidemiological studies in Europe, results on the association between TFA intake and CVD risk are less unequivocal. A recent cohort study among Finnish men revealed a signi®cantly elevated risk for coronary death in the highest (mean 5.6 gaday) compared to the lowest (mean 1.3 gaday) quintile of TFA intake. The association with coronary events, however, did not reach signi®cance after adjustment for smoking, body mass index, blood pressure, intake of energy, alcohol and ®bre, education and physical activity (Pietinen et al, 1997) . In the EURAMIC study, investigating the association between adipose tissue levels of C18:1 TFA and the risk for acute myocardial infarction (MI), no overall effect of TFA levels was observed (Aro et al, 1995) . Analysis in the separate countries, however, showed an elevated MI risk in the highest quartile of adipose TFA in Norway and Finland, and reduced risks in Spain and Russia. In a Dutch case-control study, no association was seen between the extent of coronary stenosis and TFA content of plasma phospholipids (Van de Vijver et al, 1996) .
Dietary intervention studies have most convincingly demonstrated that high TFA intake has an adverse effect on serum lipid levels (Mensink & Katan, 1990; Mensink et al, 1992; Nestel et al, 1992; . In these studies, the contribution of TFA to the diet was relatively high, accounting for 7 ± 11 en% of dietary intake. Few studies have reported on the negative effects on lipid pro®les of lower amounts of TFA added to the diet (Judd et al, 1994; Lichtenstein et al, 1993) . The high TFA groups consumed 3.6 ± 6.6en% which, however, is still 4-fold higher than that found in this study. In the present study we did not ®nd a positive association between TFA intake and LDL or total cholesterol. Possibly this can be attributed to the low intake levels found in this European population. In the intervention studies, however, a clear dose dependence was shown, at relatively high TFA intake levels. The habitual dietary intake found in the TRANSFAIR study was about 2 gaday, which is substantially lower than intake levels reported in these intervention studies (Mensink & Katan, 1990; Mensink et al 1992; Nestel et al, 1992; and in the US epidemiological studies Troisi et al, 1992; Willet et al, 1993; Ascherio et al, 1994) . Also, in Canada a high average TFA intake of 10.6 gaday for lactating women was reported (Chen et al, 1995) . This may imply that the`exposure rate' under habitual European intake levels is too low to be re¯ected in substantial changes in serum lipid levels. Another explanation for the different ®ndings in the US and Europe may possibly be ascribed to a larger diversity in eating patterns in Europe: data from the EURAMIC study already show marked differences between countries.
Epidemioloigcal studies reporting on the association between TFA intake and CVD risk do not provide data on lipid levels (Willett et al, 1993; Ascherio et al, 1994) . It can therefore not be excluded that the elevated CVD risk reported can also be ascribed to factors other than elevated lipid levels, eg an increase in lipoprotein(a) (Mensink et al, 1992) . Another explanation for the discrepant ®ndings may be that TFA intake itself is not aetiologically related to CVD risk, but that high TFA intakes are merely a marker for a speci®c eating pattern or another factor in¯uencing the CVD risk. This is in agreement with the ®ndings in the Nurse's Health Study, were no association was found between animal TFA and CVD risk (Willett et al, 1993) .
In the ®rst parts of the TRANSFAIR study, foods contributing most to the TFA intake were identi®ed. Important contributors to the TFA intake were milk and milk products including cream (Finland, Spain, Sweden), cheese (France, Greece, Portugal, Sweden), meat and meat products (Iceland, Portugal, Spain), butter (France), partially hydrogenated oils and fats (Finland, Iceland, Netherlands) and biscuits and cake (Greece, Sweden) (Hulshof et al, 1999) . Per country the type of oilafats used for the preparation of foods differed. Olive oils are commonly used in the Mediterranean countries, whereas in Iceland hydrogenated marine oils are commonly used in bakery products . From the results of the third part of the TRANSFAIR study it is also shown that the intakes of the less abundant TFA, C16:1 t9 and C22:1 t, an indication of higher intakes of hydrogenated ®sh oils, were relatively high in France and Iceland.
The recent reduction in TFA content of margarines has been reached by increasing the amount of cis-unsaturated fatty acids (Portugal, Spain) andaor by increasing the amount of C12 ± 16 saturated fatty acids (Sweden). It was shown that margarines lowest in TFA contained on average more saturated fatty acids (Aro et al, 1998a) , which also has an impact on serum lipid levels. In data from the Nurses' Health Study, the impact of changes in fatty acid consumption on CVD risk was estimated. An increase of the TFA intake with 2en% was estimated to lead up to an increased risk of CVD with 93%, whereas an increased consumption of SFA with 5en% increased CVD risk by 17% (Hu et al, 1997) . From our data no indications arose as to a more harmful effect of TFA intake in comparison to saturated fatty acid intake. The current TFA intake levels in Europe do not seem to be a reason for a major concern. Because a further reduction of TFA in European foods seems limited as a result of the high contributions of natural TFA (Van Poppel, 1998) , reduction of serum cholesterol will be reached not only by focusing on TFA intake, but also by reducing the intake of saturated fatty acids.
From this study we conclude that at the current European intake levels of trans fatty acids, they are not associated with an unfavourable serum lipid pro®le. From this and other studies the conclusion can be drawn that for reduction of cholesterol levels the focus should not exclusively be on the reduction of TFA, but also on the reduction of all cholesterol-increasing fats, including saturated fatty acids.
